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Stem cell factor (SCF)–induced activation
of phosphoinositide-3-kinase (PI3K) is re-
quired for transient amplification of the
erythroblast compartment. PI3K stimu-
lates the activation of mTOR (target of
rapamycin) and subsequent release of
the cap-binding translation initiation fac-
tor 4E (eIF4E) from the 4E-binding protein
4EBP, which controls the recruitment of
structured mRNAs to polysomes. En-
hanced expression of eIF4E renders pro-
liferation of erythroblasts independent of
PI3K. To investigate which mRNAs are
selectively recruited to polysomes, we
compared SCF-dependent gene expres-
sion between total and polysome-bound
mRNA. This identified 111 genes primarily
subject to translational regulation. For
8 of 9 genes studied in more detail, the
SCF-induced polysome recruitment of
transcripts exceeded 5-fold regulation and
was PI3K-dependent and eIF4E-sensitive,
whereas total mRNA was not affected by
signal transduction. One of the targets,
Immunoglobulin binding protein 1 (Igbp1),
is a regulatory subunit of protein phos-
phatase 2A (Pp2a) sustaining mTOR sig-
naling. Constitutive expression of Igbp1
impaired erythroid differentiation, main-
tained 4EBP and p70S6k phosphoryla-
tion, and enhanced polysome recruit-
ment of multiple eIF4E-sensitive mRNAs.
Thus, PI3K-dependent polysome recruit-
ment of Igbp1 acts as a positive feedback
mechanism on translation initiation under-
scoring the important regulatory role of
selective mRNA recruitment to polysomes
in the balance between proliferation and
maturation of erythroblasts. (Blood. 2008;
112:2750-2760)
Introduction
The balance between expansion and differentiation of hematopoi-
etic progenitor compartments is controlled by cytokines and
growth factors. In erythropoiesis, stem cell factor (SCF), the ligand
for cKit, cooperates with glucocorticoids and erythropoietin (Epo)
to suppress differentiation and sustain renewal divisions of
erythroblasts in vitro1,2 as well as in vivo.3,4 Activation of
phosphotidylinositol-3 kinase (PI3K) is essential for proliferation
of erythroblasts.2,5-8 Activated PI3K generates PIP3, which serves
as an anchor for multiple PH-domain–containing proteins, such as
protein kinase B (PKB). Although both Epo and SCF induce
activation of PI3K in erythroblasts, the efficiency with which
respective downstream signaling pathways are activated shows
large differences.9,10 In cultured erythroblasts, the activation of
PKB is much more responsive to SCF compared with Epo. PKB
activates mammalian target of rapamycin (mTOR) through phos-
phorylation of the tumor suppressor complex Tsc1/Tsc2 (tuberous
sclerosis protein), which releases RAS homolog enriched in brain
(Rheb) to phosphorylate mTOR.11,12 Activation of mTOR results in
phosphorylation and activation of p70S6 kinase (Rps6kb1)13 and
hierarchical phosphorylation of 4E-binding protein (4EBP),14,15
resulting in release of the mRNA cap-binding factor eukaryotic
initiation factor 4E (eIF4E).16 Subsequently, eIF4E can bind the
scaffold protein eIF4G to the site otherwise occupied by 4EBP,
which enables the formation of an eIF4F-scanning complex
containing eIF4E, eIF4G, and the RNA helicase eIF4A.17 eIF4F
associates with several other translation factor complexes, includ-
ing eIF3, eIF2, and the ribosomal subunits.18 This complex scans
the 5UTR for the first AUG codon in an appropriate sequence
context to start protein synthesis.19 eIF4E is the rate-limiting factor
in the scanning process,20,21 and its release on phosphorylation of
4EBP is a crucial control mechanism in the recruitment of mRNAs
to polysomes. Importantly, transcripts with a short and simple
5UTR show a limited sensitivity to 4EBP phosphorylation,
whereas transcripts with a long and structured 5UTR or with a
terminal oligopyrimidine tract (TOP) are highly sensitive to the
concentration of eIF4F complexes in the cell.19,22,23
The mechanism by which mTOR controls 4EBP phosphoryla-
tion involves regulation of 4EBP-phosphorylation but also regula-
tion of the serine/threonine phosphatase Pp2a,24-27 which can
dephosphorylate p70S6K and 4EBP, thereby suppressing transla-
tion initiation. Pp2a exists in various complexes that shift target
specificity depending on the binding of regulatory components.
Binding of the 4 subunit (designated immunoglobulin binding
protein 1 [Igbp1]) to the Pp2a catalytic subunit modifies Pp2a
phosphatase activity. mTOR stimulates the formation of the
Pp2a-4 complex, which was shown to sequester the phosphatase
activity away from its own downstream targets 4EBP and p70S6
kinase.26,28 The effects of Pp2a-4 complex formation, however,
may be context dependent,29 and Igbp1(4) has additional func-
tions, for instance, in stabilizing the interaction of the midline
complex with microtubules.30
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We showed that 4EBP is potently phosphorylated by SCF,10 and
described 3 transcripts that require SCF-induced PI3K/mTOR
activation to be recruited to polysomes, whereas SCF does not
affect their transcript levels.10 We also demonstrated that overexpres-
sion of eIF4E increased the levels of eIF4F complexes and
suppressed erythroid differentiation in the absence of SCF. Thus,
mechanisms that control eIF4F formation are important to regulate
the balance between expansion and differentiation in erythropoi-
esis,10 in line with reports stating that overexpression of eIF4E in
tumor samples is associated with increased malignancy.31-34 Appar-
ently, selective mRNA translation plays a major role in erythropoi-
esis, but knowledge on mRNAs subject to factor-dependent
polysome recruitment remained scarce.
In this study, we compared factor-dependent mRNA expression
in total and polysome-bound (pb) mRNA and identified 111 tran-
scripts that require PI3K or increased eIF4F levels for polysome
recruitment. From these we selected 9 genes suspected to be
involved in signal transduction or gene expression and analyzed
their expression regulation and biologic function in erythroblasts.
Except for one gene that was regulated by both gene transcription
and mRNA translation, the selected genes were strictly regulated
by polysome recruitment in response to SCF-induced activation of
PI3K and eIF4F formation. Strikingly, we identified the Pp2a-
associated protein Igbp1 (4 subunit of Pp2a) as a target of
SCF-dependent polysome recruitment. Constitutive expression of
Igbp1 in erythroblasts enhanced the mTOR-dependent phosphory-
lation of S6K and 4EBP. Exogenous Igbp1 strongly impaired
differentiation of erythroblasts and enhanced polysome recruitment
of other target gene mRNAs identified in this screen.
Methods
Cell culture
I/11 cells were cultivated in StemPro-34 (Invitrogen, Breda, The Nether-
lands).2 For expansion, the medium was supplemented with 0.5 U/mL of
Epo, (kind gift from Ortho Biotech Products, Tilburg, The Netherlands),
100 ng/mL of SCF (supernatant of CHO producer cells), and 106 M of
dexametasone (Dex; Sigma-Aldrich, St Louis, MO). To induce differentia-
tion, cells were cultivated in StemPro-34 supplemented with 5 U/mL of Epo
and 0.5 mg/mL of iron-loaded transferrin (Scipac, Sittingbourne, United
Kingdom). Cell numbers and cell size distribution were determined using
an electronic cell counter (CASY-1; Scha¨rfe-System, Reutlingen, Ger-
many). LY294002 (10 M in final volume) and rapamycin (40 ng/mL)
were obtained from Alexis (Lausen, Switzerland); actinomycin D (10 g/
mL) and cycloheximide (50 g/mL) were from Sigma-Aldrich.
Hemoglobin content and cell morphology
Small aliquots of the cultures were removed and analyzed for hemoglo-
bin content by photometry as described.9,35 Cell morphology was
analyzed in cytospins stained with histologic dyes and neutral benzi-
dine,36 using an OlympusBX40 microscope (40 objective, NA 0.65),
an OlympusDp50 CCD camera, and Viewfinder Lite 1.0 acquisition
software. Images were cropped using Adobe Photoshop version
6.0 (Adobe Systems, Mountain View, CA).
Microarray hybridization and analysis
A MIAME-compatible description of sample preparation and hybridization
protocols is given in Document S1 (available on the Blood website; see the
Supplemental Materials link at the top of the online article). Microarray
data were analyzed using the Rosetta Resolver system, as described.37 All
microarray data have been deposited at http://www.ebi.ac.uk/microarray-as/
ae/browse.html?keywordsE-MEXP-1689.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis,
Western blotting, and antibodies
For acute stimulation with growth factors, proliferating I/11 cells were
washed twice with phosphate-buffered saline (PBS) and seeded at
4  106 cells/mL in plain Iscove modified Dulbecco medium (IMDM,
Invitrogen). After 4 hours of factor deprivation, cells were stimulated
at 37°C with SCF (100 ng/mL) or Epo (5 U/mL). Cells were harvested
by addition of ice-cold PBS. Cell lysates, sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE), immunoprecipitation,
and Western blotting were performed as described38; 10 L of protein
extract (1  106 cells) was loaded onto a 15% polyacrylamide gel. The
antibodies used were -4EBP1 (Cell Signaling Technology, Danvers, MA),
-Uhmk1 (gift from M. Boehm, National Institutes of Health/National
Heart, Lung, and Blood Institute), -Igbp1 (gift from D. L. Brautigan,
Center for Cell Signaling, University of Virginia, Charlotesville), S6K-P
(Cell Signaling Technology), and -Fli1 and -Myc (Santa Cruz Biotech-
nology, Santa Cruz, CA).
Transduction of I/11 clones
The coding sequences of selected genes were amplified from cDNA derived
of I/11 cells using Pfu polymerase (M7741; Promega, Leiden, The
Netherlands) and primers designed to insert an EcoRI at the 5 end and a
ClaI site at the 3 end of the polymerase chain reaction (PCR) product
(Table S4). The PCR product was inserted in TA vector (KNM2040-01;
Invitrogen); subsequently, the EcoRI/ClaI fragment was transferred to a
pBlueScript vector. The PCR primer inserted the ATG of the coding
sequence in frame to a 6-myc-tag sequence at the EcoRI site of the
pBlueScript vector. Next, a BamHI/SalI fragment containing the N-terminal
myc-tag and the coding sequence was inserted into the retroviral expression
vector pBabe. Retroviral transduction was performed as described.9
RNA isolation and cDNA synthesis for PCR
Isolation of polysomal RNA by sucrose gradient fractionation was per-
formed as described.10,39 Total RNA was isolated by the same protocol,
omitting the density centrifugation. Cell extracts were layered on a 4-mL
linear sucrose gradient (15%-40% sucrose wt/vol), and 8 fractions were
collected. Northern blotting indicated that fractions 1 to 4 contain nonpoly-
somal and subpolysomal mRNA, whereas fractions 5 to 8 consisted of pb
RNA. These fractions were pooled to generate subpolysomal and polyso-
mal mRNA of each sample. RNA was quantified by UV-absorbance.
Poly(A) mRNA was purified and cDNA was generated as described.39
Real-time PCR
Real-time PCR was performed using SYBR green and a Taqman PCR
machine (model 7700 sequence detector, Applied Biosystems, Foster City,
CA).40 The amplification program started with 2 minutes at 50°C (Amp-
Erase UNG incubation), 10 minutes at 95°C (AmpliTaq Gold Activation),
followed by 40 cycles of 15 seconds’ denaturation at 95°C, 30 seconds of
annealing at 62°C, and 30 seconds’ of extension at 72°C. All primer pairs
had similar PCR annealing temperatures. To confirm amplification specific-
ity, the dissociation curve was checked at the end of each run, and PCR
products from each primer pair were checked by gel electrophoresis.
Gene-specific primers are listed in Table S5 and were obtained from
Invitrogen or Sigma-Genosys (The Woodlands, TX).
Results
Transcripts dependent on Epo/SCF induced polysome
recruitment
To identify mRNA transcripts that are selectively recruited to
polysomes on growth factor stimulation of erythroblasts, we
compared factor-induced gene expression at the level of total and
pb RNA using mRNA profiling. We used immortalized p53/
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erythroblasts having a lifespan that allows analysis on large
numbers of cells while closely resembling primary progenitors.1
The lack of p53 will make a difference, for instance, in response to
DNA damage, but not in response to mitogenic factors. Erythro-
blasts were factor-deprived (4 hours) and restimulated (2 hours)
with Epo plus SCF, or left unstimulated. Four independently
generated replicates were prepared from 2 established p53/
erythroblast cultures with different genetic background (I/11 and
R10).2,41 Total and pb RNA were isolated twice from each culture,
cRNA was generated and hybridized to Affymetrix oligonucleotide
arrays. Rosetta Resolver software was used to normalize and
analyze the intensity data as described37; samples are described in
Table S1. The ratio of gene expression in Epo/SCF stimulated
samples (ES) versus factor-deprived cells (NF) was calculated for
total and pb mRNA (Figure 1A). Next, we applied a 2-step
selection to identify genes differentially regulated in total versus pb
RNA. First, genes with sufficient variance between the ES/NF
ratios for total and pb RNA were selected by analysis of variance
(P  .01). Second, selected genes had to be differentially ex-
pressed in presence or absence of Epo/SCF in total or pb mRNA in
either both I/11 or in both R10 hybridizations (P  .001; for details
on this strategy, see Document S1). This approach selected
115 probe sets representing 111 different transcripts subject to
Epo/SCF-controlled polysome recruitment (Table S5). To relate
differential polysome recruitment to gene expression during differ-
entiation, we derived pb mRNA from steady-state expanding and
differentiating erythroblasts (48 and 60 hours after differentiation
induction; again, 4 independent replicates). After hybridization of
oligonucleotide arrays, the gene expression ratio of differentiation
over steady-state renewal was calculated. Subsequent cluster
analysis of gene expression ratios of the 115 selected probe sets
resulted in a matrix that groups the selected probe sets into 5
separate clusters based on Epo/SCF-controlled gene expression
detected in total and pb RNA and on expression during differentia-
tion (Figure 1B; Table S5).
Genes represented in clusters 1, 3, and 5 (83 genes) were
subject to Epo/SCF-induced polysome recruitment; clusters
1 and 3 were also characterized by decreased expression during
differentiation. To gain further insight into regulation of gene
expression in the various clusters, we compared normalized
intensity data obtained from the array hybridization with total
and pb RNA from factor-deprived and Epo/SCF-restimulated
cells (Figure S1). Cluster 1 represents genes with constitutive
expression in total RNA and Epo/SCF-induced polysome recruit-
ment. Cluster 3 represents genes of which transcription is
increased by growth factor stimulation, but polysome recruit-
ment shows a more pronounced increase in response to Epo/
SCF. Cluster 5 represents genes characterized by Epo/SCF-
induced repression of expression in total mRNA, but with
maintained levels in pb RNA, which implies increased Epo/SCF-
induced polysome recruitment from a smaller transcript pool.
Genes present in clusters 2 and 4 are subject to enhanced
polysome recruitment after factor deprivation, which is abro-
gated by Epo/SCF restimulation (Figure S1). These genes may
play a role in the initiation of stress responses. Only genes
represented by cluster 4 were up-regulated during differentiation.
Polysome recruitment of selected transcripts depends on the
PI3K/mTOR/eIF4E pathway
Next, 9 genes were selected that (1) require Epo/SCF for polysome
recruitment, (2) are down-regulated in differentiation, (3) are
suggested to function in signal transduction or control of gene
expression, and (4) were hitherto not known to be translationally
regulated (Table 1; for details on these genes, see Table S2).
Quantitative reverse-transcribed PCR (Q-PCR) was used to ana-
lyze whether polysome recruitment was dependent on PI3K and
mTOR, and on eIF4E expression.
First, we tested how signal-dependent expression in total and pb
RNA correlates between array data and Q-PCR. We determined
transcript levels in subpolysomal and pb RNAby Q-PCR and calculated
the percentage polysome recruitment. In addition to the 9 selected genes,
Nm23-M2 (Nme2) and Ybx1 were tested as positive controls.10 Acontrol
gene, Fli-1, that is not regulated at the level of RNA-specific polysome
recruitment, showed at most a 2-fold difference in polysome recruitment
in response to Epo or SCF (Table 1; Figure 2C,F). In contrast, Nme2,
Ybx1, and 8 of 9 of the selected genes showed a 10-fold increase or more
in polysome recruitment in response to Epo plus SCF; only Grwd1
failed to reproduce the regulation detected on the arrays (Table 1; Figure
2A,B,D,E). The SCF-induced increase in polysome recruitment ex-
ceeded Epo-induced polysome recruitment, whereas Epo plus SCF
showed an additive or even synergistic effect (Table 1, Figure 2D,E).
Cluster 1 genes Igbp1, mEd2, Rnf138, Nap1l1, and Cnih, cluster 3 gene
Nubp1, and cluster 5 gene Uhmk1 were almost exclusively up-regulated
in pb but hardly in total mRNA (Table 1); cluster 5 gene Hnrpa1 was
down-regulated in total mRNAin accordance with the array data (Tables
1 and S5). Inhibition of PI3K (LY294002) or mTOR (rapamycin)
decreased polysome recruitment of the control gene Fli-1 approximately
2-fold but completely dissociated all other genes from polysomes (Table
1; Figure 2D-F).
Figure 1. Cluster analysis of genes subject to regulation by Epo/SCF-controlled
mRNA polysome recruitment and their regulation during differentiation.
(A,B) Cells from the I/11 and R10 line were factor-deprived for 4 hours and stimulated
with Epo plus SCF (ES) or left untreated (NF) for 2 hours. Total RNA and
polysome-bound (pb) mRNAwere isolated and used for RNAprofiling on MG_U74Av2
Affymetrix oligonucleotide arrays. For each of 2 biologically independent experiments
(I/11a and I/11b; R10a and R10b), the ES/NF ratio of intensity data was calculated.
Significant variance between ES/NF ratios obtained with total and pb RNA was
calculated using ANOVA (P  .01). In addition, differential expression in at least
2 single experiments had to be significant (P  .001). This selection yielded
115 probe sets. For these genes, the expression ratios after 48- or 60-hour
differentiation induction were calculated compared with proliferation conditions
(diff t48/t0 and t60/t0). Expression ratios were clustered using Rosetta software and
Pearson correlation. Bar (top left corner) represents correlation of up- and down-
regulation with the intensity of red and blue, respectively, on a log-10 scale.
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Overexpression of eIF4E is expected to render the selected
transcripts less sensitive to Epo/SCF-induced PI3K activity.10
Indeed, polysome recruitment of all transcripts became partially
factor independent in cells overexpressing eIF4E (Table 1 and
Figure 2G,H; for cells, see Blazquez-Domingo et al10). Effects in
the Fli-1 controls were again maximally 2-fold (Figure 2I).
We previously showed that PI3K activity is required for the
expansion of erythroblast cultures. Overexpression of eIF4E ren-
dered cells independent of PI3K activation and impaired differen-
tiation.2,10 Therefore, proteins whose expression is controlled by
PI3K- and eIF4E-dependent mRNA polysome recruitment are
expected to be required during erythroblast proliferation. pb
mRNA was isolated from I/11 cells induced to differentiate, and
Q-PCR showed that the selected genes were all down-regulated
during differentiation (Table 1; Figure 2J,K). The erythroid transcrip-
tion factor Nfe2 is known to be up-regulated during differentiation
and is shown as a control (Figure 2L).
In conclusion, translation of 10 of 11 transcripts selected from
83 genes subject to Epo/SCF-induced polysome recruitment (Igbp1,
mEd2, Rnf138, Nap1l1, Cnih, Nubp1, Uhmk1, Hnrpa1, Nm23-M2, and
Ybx1) was strictly controlled by the PI3K-mTOR-eIF4E pathway.
Epo/SCF-dependent protein expression of Igbp1 and Uhmk1
The high-density complexes with which the transcripts associated
in response to PI3K activation and eIF4E expression are assumed
to be polysomes. Potentially, however, these could represent
high-density hnRNP complexes. To examine whether the associa-
tion of transcripts in high-density complexes reflects protein
expression, we analyzed protein expression of Igbp1 and Uhmk1
Figure 2. Polysome recruitment of Igbp1 and mEd2 is
PI3K and eIF4E sensitive. I/11 cells were factor-
deprived for 4 hours and subsequently restimulated with
Epo (E, 2U/mL), SCF (S, 100 ng/mL), or both (ES) for
2 hours. Where indicated, LY294002 (LY; 10 M) or
rapamycin (R; 10 nM) was added 30 minutes before and
during restimulation. Total RNA as well as free and pb
RNA fractions were isolated, and gene expression was
measured by real-time PCR. (A-C) The expression ratio
in restimulated versus factor-deprived cells is calculated
as a log-2 fold-change for Igbp1 (A), mEd2 (B), and Fli1
(C); in total () and pb mRNA (f). (D-F) The percentage
of mRNA associated with polysomes (pb-mRNA) was
calculated for the same genes under the different condi-
tions. (G-I) I/11 cells transduced with an empty control
vector (f) or with an eIF4E expression vector (eIF4E
overexpression, ) were factor-deprived and restimu-
lated as indicated. The percentage pb mRNA was calcu-
lated for Igbp1 (G), mEd2 (H), and Fli1 (I). (J-L) I/11 cells
were induced to differentiate and total RNA was isolated
before (t0) and 24 (t24), 48 (t48), and 72 hours (t72) after
differentiation induction. The expression ratio in differenti-
ated vs nondifferentiated cells was calculated as a log-2
fold-change for Igbp1 (J), mEd2 (K), and Nfe2 (L). Error
bars were calculated from 4 independent measurements
using 2 different RNA batches.
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on Western blot and compared it with factor-dependent protein
expression of Fli-1. In contrast to Fli-1, expression of Igbp1 and
Uhmk1 was more sensitive to inhibition of translation compared
with inhibition of transcription (Figure S2). Restimulation of
factor-deprived erythroblasts with Epo and SCF rapidly increased
Igbp1 and Uhmk1 protein expression, which was inhibited by
rapamycin and CHX. Fli-1 expression, however, was inhibited by
CHX, but not by rapamycin (Figure S2). Igbp1 protein expression
was also enhanced in cells constitutively expressing eIF4E (Figure
S5). Thus, factor-dependent Igbp1 and Uhmk1 protein expression
was appropriately reflected by RNA present in high-density
polysomes.
Functional analysis of target genes
Because SCF-induced activation of the PI3K-mTOR-eIF4E path-
way sustains expansion and delays differentiation of erythroblast
cultures, we investigated the functional role of the proteins
requiring this pathway for their expression. From the 8 selected
genes that showed PI3K-dependent polysome recruitment, 7 were
expressed from retroviral expression vectors downstream of a
myc-epitope tag (introducing the ORFs without the UTRs that
control translation; for unclear reasons, Nubp1 resisted cloning in
pBabe). Expression of selected genes in Phoenix cells was checked
on Western blots, and correct cellular distribution of these proteins
was assessed by immunofluorescence (Figure S3). The expression
vectors were transduced into I/11 cells, and single cell-derived
clones were established, generating empty vector control clones in
every respective experiment.
With 4 of the 7 genes (Uhmk1, Cnih, Rnf138, and Nap1l1), we
repeatedly failed to establish I/11 clones stably expressing these
genes despite proper transient expression in Phoenix cells. Hnrpa1,
Igbp1, and mEd2 (2010315L10Rik) were expressed in Phoenix and
I/11 cells, and several single cell-derived I/11 clones were estab-
lished (Figure S4 and data not shown). To analyze if and to what
extent these 3 proteins mimic SCF-induced suppression of differen-
tiation, clones positive for exogenous protein expression were
subjected to differentiation conditions (Epo plus iron-loaded trans-
ferrin). Differentiation parameters, including cell number, mean cell
volume, hemoglobin per cell volume, and cell morphology, were
analyzed at various time points (Figure 3; and data not shown). On
induction of differentiation, empty vector-transduced control cells
showed the expected transient proliferation (	3 divisions within
48 hours) and hemoglobin accumulation (Figure 3A), accompanied
by size decrease and a predominantly mature normoblast/
erythrocyte morphology (Figure 3D). Constitutive expression of
Hnrpa1 yielded similar results as empty vector (data not shown),
whereas expression of Igbp1 and mEd2 impaired differentiation.
Erythroblasts constitutively expressing Igbp1 proliferated exponen-
tially for more than 72 hours, remained large, hardly accumulated
hemoglobin, and maintained a blast-like morphology (Figure
3B,D). Erythroblasts constitutively expressing mEd2 were partially
impaired in differentiation; the cells became smaller but did not
accumulate hemoglobin and showed a partially differentiated
morphology (Figure 3C,D). In these experiments, we used the
mEd2 ORF published to enhance an ERK-dependent reporter
construct (PM26).42 We also expressed a longer cDNA, recently
described to encode the novel Q-SNARE protein D12 (Use1) in
Phoenix cells.43 The intracellular localization of D12 was similar to
mEd2, but we failed to express the D12 protein in I/11 cells,
suggesting that the truncated protein inhibits differentiation,
whereas the full-length protein seems incompatible with erythro-
blast proliferation.
Transforming growth factor-
 (TGF-
) counteracts the effect of
SCF and enhances differentiation of erythroblasts in presence of
Epo plus SCF (H.B., M.v.L., unpublished data, June 2000).
Therefore, we examined whether TGF-
 could induce differentia-
tion of cells constitutively expressing Igbp1. In the presence of Epo
plus SCF, the constitutive expression of Igbp1 in I/11 cells
enhanced proliferation (Figure 4A,B), completely prevented the
slow size decrease seen in control cells, and fully inhibited
hemoglobin accumulation and morphologic maturation (Figure
4C-G). As expected, addition of TGF-
 inhibited proliferation and
accelerated differentiation of control cells (Fig 4A,C,E). TGF-

also induced differentiation in Igbp1 expressing erythroblasts but
to a much lesser extent. Compared with control cells, the addition
of TGF-
 to the Igbp1 expressing cells showed delayed onset of
inhibition of proliferation (day 5 instead of day 2), size decrease
Figure 3. Overexpression of Igbp1 and mEd2 impairs differentiation of I/11
erythroid progenitors. I/11 cells transduced with an empty vector (EV; A) or Igbp1
(B) or mEd2 (C) expression vectors were seeded in differentiation medium. Four
single-cell–derived clones for each construct were analyzed at regular intervals
during 4 days. Cumulative cell numbers (left panels) and hemoglobin content per cell
volume (arbitrary units [a.u.], right panels) were measured. (D) At day 3, cells were
harvested for cytospins and stained for hemoglobin (brown) and histologic dyes.
Hemoglobinized and enucleated erythrocytes are abundant in control cells, whereas
Igbp1- and mEd2-expressing cells contain mainly blasts.
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(day 4 instead of day 1), and hemoglobinization (maximal at day
7-8 instead of day 3-4; Figure 4B,D,F). In line with this, TGF-
–
treated Igbp1 expressing erythroblasts were still largely immature
at the time (t96), whereas most control cells were in an advanced
state of maturation (small and hemoglobinized, Figure 4G). In
conclusion, TGF-
 induced only a limited differentiation in
Igbp1-expressing cells, which suggests that Igbp1 may interfere
with aspects of TGF-
 signaling.
Igbp1 affects 4EBP and p70S6k phosphorylation
Igbp1 associates with the serine/threonine phosphatase Pp2a to
modulate Pp2a phosphatase activity toward its different targets.26,28
Among these targets are 4EBP and p70S6k.44,45 We analyzed Epo-
and SCF-induced phosphorylation of 4EBP and p70S6k in Igbp1-
expressing I/11 cells and respective control cells. As previously
shown, SCF but not Epo induced full phosphorylation of 4EBP.10
On constitutive expression of Igbp1, however, stimulation of
Figure 5. Constitutive Igbp1 expression increases phosphorylation of 4EBP
and S6K and enhances Epo-induced polysome recruitment of structured
transcripts. (A,B) I/11 cells transduced with an empty control vector (vector) or with
an Igbp1 expression vector were factor-deprived (4 hours), stimulated with Epo (E,
5 U/mL), SCF (S, 100 ng/mL), or Epo plus SCF (ES), or left untreated (NF).
Expanding I/11 cells in the presence of Epo, SCF, and dexamethasone are steady
state (ss). (A) Western blots from total cell lysates were stained with antibodies
recognizing total 4EBP (4EBP Ab). The nonphosphorylated, hypophosphorylated,
and hyperphosphorylated proteins can be discriminated by their distinct electro-
phoretic mobility as , 
, and  isoforms, respectively. (B) Western blots from
samples stimulated as indicated for 10 minutes were stained with a phospho-specific
antibody against p70S6K (P-S6K) and counterstained for total S6K to control for
equal loading. (C-H) Expanding I/11 empty vector control cells (f) or cells constitu-
tively expressing Igbp1 () were factor-deprived and left untreated (NF) or restimu-
lated with erythropoietin (Epo, 2 U/mL; 2 hours). Free and polysome-bound mRNA
was isolated and assayed for the expression of Fli-1 (C), Igbp1 (D), eEF1 (E), rps4
(F), Nm23 (G), and mEd2 (H). The percentage of mRNA associated with polysomes
(pb-mRNA) was calculated for the different genes under the different conditions.
Constitutive Igbp1 expression enhances polysome recruitment of translationally
controlled transcripts in response to Epo alone.
Figure 4. Igbp1 expression delays and impedes TGF-–induced differentiation
in Epo/SCF-treated erythroblasts. Three clones transduced with empty vector (EV;
A,C,E) or Igbp1 expression constructs (Igbp1; B,D,F) were cultured in the presence
of Epo and SCF but without Dex, supplemented (black symbols) or not supplemented
(white symbols) with 20 ng/mL of TGF-
. Cumulative cell numbers (A,B), mean cell
volume (C,D), hemoglobin per cell volume (E,F), and cell morphology (G) were
examined at day 4 (t96) or 5 (t120) after differentiation induction. (See also legend to
Figure 3).
2756 GRECH et al BLOOD, 1 OCTOBER 2008  VOLUME 112, NUMBER 7
 For personal use only. at Erasmus MC Medical Library on August 4, 2009. www.bloodjournal.orgFrom 
erythroblasts by Epo was sufficient to induce hyperphosphorylation
of 4EBP (Figure 5A). Phosphorylation of p70S6k required the
presence of both Epo and SCF in control cells. Interestingly,
constitutive expression of Igbp1 increased Epo-induced phosphor-
ylation of p70S6k to levels obtained only with Epo plus SCF but
did not enhance SCF-induced phosphorylation of p70S6k (Figure
5B). Apparently, the activation of p70S6K requires at least 2
cooperating pathways: SCF-induced activation of Igbp1 plus an
Igbp1 independent pathway activated by Epo. The enhanced
phosphorylation of 4E-BP and p70S6k in Igbp1-expressing cells in
the presence of Epo is in line with enhanced proliferation and
impaired differentiation of Igbp1-expressing erythroblasts in the
presence of Epo only.
Constitutive expression of 4 enhances polysome recruitment
of eIF4E-sensitive mRNAs
Next we tested whether constitutive expression of Igbp1 also
enhances translation of transcripts previously found to depend on
increased levels of free eIF4E. Expression levels of various genes
were measured by Q-PCR in subpolysomal and pb mRNA fractions
isolated from empty vector control erythroblasts and erythroblasts
constitutively expressing Igbp1. Polysome recruitment of Igbp1
itself was increased on factor deprivation and Epo restimulation
(Figure 5D), which is expected as the expressed construct lacks the
regulatory sequences responsible for factor-dependent translation.
Polysome recruitment of Fli-1, which is not subject to factor-
dependent translation, is not affected by Igbp1 expression (Figure
5C). However, 2 transcripts with a terminal oligopyrimidine tract,
eIF1
 and Rps4, as well as 2 transcripts with a highly structured
5UTR, mEd2 and Nm23-M2, show increased polysome recruit-
ment, both during steady-state expansion and after Epo stimulation
(Figure 5E-H). Together, these data indicate that translational
control of Igbp1 is an important positive feedback signal to
enhance polysome recruitment of eIF4E-sensitive mRNAs.
Discussion
Activation of the PI3K-mTOR-eIF4E pathway is an important
mechanism by which SCF delays differentiation and sustains
proliferation of erythroblasts.10 This suggests that selective poly-
some recruitment of eIF4E-sensitive mRNAs is crucial to erythro-
poiesis. In this study, we identified a unique set of genes that are
hardly regulated at the level of gene transcription but depend on
SCF-induced, PI3K-dependent increase in eIF4F complexes to be
recruited to polysomes. Functional analysis revealed that constitu-
tive expression of one of these genes, Immunoglobulin binding
protein 1 (Igbp1, also known as the 4 subunit of Pp2a), strongly
impaired terminal differentiation of erythroblasts. Constitutive
expression of Igbp1 maintained phosphorylation of 4EBP and
p70S6K in the presence of Epo to levels otherwise only obtained in
presence of SCF. Igbp1 appeared to function in a positive feedback
loop of mTOR-regulated polysome recruitment of eIF4E-sensitive
mRNAs (Figure 6). Our data emphasize the important role of
selective polysome recruitment in control of gene expression and
cell fate determination.
Specific transcripts recruited to polysomes by SCF signaling
We show that polysome-bound mRNA profiling, integrating gene
expression control at the level of transcription, mRNA nuclear
export, and polysome recruitment,46,47 allowed the identification of
multiple genes that were regulated specifically at the level of
polysome recruitment via Epo/SCF signaling and would not be
detected by standard mRNA profiling. One of these genes, Igbp1,
was critically involved in regulating erythroid progenitor renewal
versus differentiation. This indicates that polysome recruitment is
an important level at which signaling-dependent gene expression
regulates erythropoiesis. Rajasekhar et al demonstrated PI3K- and
Mek1-dependent, selective polysome recruitment of mRNA in
v-Ras/v-Akt transformed glioblastoma cells.48 Others identified
transcripts that are specifically recruited to polysomes on overex-
pression of eIF4E in mouse embryo fibroblasts49 or in human
epithelial cells.50 We found little overlap between genes identified
in our studies because of differences in cell type and experimental
approach. Notably, overexpression of eIF4E improved polysome
recruitment of, eg, Nm23-M2 and Igbp1 in absence of PI3K
activity, but not to levels obtained by full stimulation with
Epo/SCF. This suggests that polysome recruitment of the targets
identified in our screen may depend on additional mechanisms that
the other screens did not select for. Together, however, screens
using polysome-bound bound mRNA indicate that regulation of
gene expression at the translational level is an important mecha-
nism in development and cancer.51,52
Selective polysome recruitment depends on UTR elements
SCF signaling stimulates cap-dependent translation and is expected
to identify transcripts that require increased levels of the eIF4F
Figure 6. Activation of PI3K is essential for proliferation of erythroblasts.
Activated phosphotidylinositol-3 kinase (PI3K) generates phosphatidylinositol (3,4,5-
triphosphate (PIP3), which serves as an anchor for multiple PH-domain containing
proteins, such as phosphoinositide-dependent kinase 1 and 2 (PDK1/2) transducing
signals to the protein kinase B (PKB) pathway. PKB activates mammalian target of
rapamycin (mTOR) through phosphorylation of the tumor suppressor complex
Tsc1/Tsc2 (tuberous sclerosis protein), which releases RAS-homolog enriched in
brain (Rheb). Activation of mTOR results in phosphorylation and activation of p70S6
kinase (S6K),13 and hierarchical phosphorylation of 4E-binding protein (4EBP),
resulting in release of the mRNA cap-binding factor eukaryotic initiation factor 4E
(eIF4E). Subsequently, eIF4E can bind the scaffold protein eIF4G, which enables the
formation of the eIF4F scanning complex at the cap (methyl-7-guanidine; m7G) of
transcripts. Igbp1 has the capacity to sequester the catalytic domain of Pp2a (Pp2aC),
preventing dephosphorylation of both 4EBP and p70S6K, resulting in enhanced
translation initiation efficiency.
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complex. It is broadly accepted that these transcripts are character-
ized by structured 5UTRs.22,31 Our list of translationally regulated
genes contained ribosomal proteins and some translation factors
assumed to contain a TOP sequence53 (Rps10, Rpl10a, Rpl18,
Rpl26, Rpl36, and eIF3s12 in cluster 1; Rps5, Rps16, Rpl22l1 and
Rpl27a in cluster 5; Table S5). Many other ribosomal proteins,
however, failed to pass the thresholds we set for signaling-
dependent polysome recruitment, suggesting that a TOP sequence
alone fails to impose strong, signal-regulated translational control
on a transcript. The genes selected for functional analysis lacked a
TOP sequence, but other structural RNA motifs that contribute to
control of translation initiation are difficult to recognize. Most of
such structured 5 UTRs are incompletely represented in the
databases because structures hamper reverse transcription. Even
knowledge of the correct 5 UTR does not always allow for
recognition of the structural configuration that controls polysome
recruitment, examples being the stem-loop iron response element54
or the consensus pseudoknot structure bound by Fragile-X mental
retardation protein (Frm1).55 Besides such structures, upstream
AUGs (uAUG) may affect polysome recruitment because transla-
tion of upstream open reading frames (uORF) can modulate
translation of the proper ORF.56,57 We have been able to elongate
the 5UTR of Igbp1, mEd2, and Nm23-M2 beyond the reported
cDNA start, using RACE experiments at increased temperatures to
facilitate melting of secondary structure, and detected potential
stem-loop structures and uAUGs in these genes (A. Nieradka,
G.G., M.v.L., unpublished data, December 2006).
The role of Igbp1 in erythropoiesis
The activity of the central regulator of protein synthesis, mTOR, is
modulated by a variety of signals.18 Polysome recruitment of
transcripts that require activation of the PI3K/mTOR/eIF4E path-
way are sensitive not only to SCF but also to amino acid starvation
and lack of cAMP.58,59 The serine/threonine phosphatase Pp2a is
one of the potential antagonist of mTOR.60 Functional Pp2a
consists of a catalytic subunit (Pp2aC), a structural subunit (Pp2aA),
and a variable regulatory subunit (Pp2aB).61,62 One of these
regulatory subunits is Igbp1, also known as 4. The interaction of
Pp2a with Igbp1 was shown to inhibit its activity toward 4EBP and
p70S6K,44,45 but Pp2a activity on other targets is enhanced.30 Pp2a
has been implied in mTOR-regulated polysome recruitment as
addition of rapamycin disrupts the Pp2a/Igbp1 complex,26 chang-
ing the constitution of the Pp2a trimeric protein.63 However, most
of these studies used ectopic expression studies, factor-independent
cell lines, or otherwise nonphysiologic conditions. We showed here
that constitutive expression of Igbp1, similar to addition of SCF,
potently attenuated and delayed differentiation of erythroblasts in
the presence of Epo. Igbp1 binds and regulates Pp2a and may
prevent dephosphorylation of both 4EBP and p70S6K as de-
scribed,44,45 which stimulates polysome recruitment of respective
signal regulated transcripts important for erythropoiesis. This is
supported by the following observations: (1) Constitutive Igbp1
expression enhances phosphorylation of 4EBP and p70S6K in
presence of Epo to levels normally reached by Epo plus SCF
(Figure 5A,B). (2) TGF-
 is not able to induce differentiation of
Igbp1 expressing I/11 cells. TGF-
 induces association of the
catalytic subunit of Pp2a (Pp2aC) with a different regulatory
subunit (Ppp2r5a or B) that stabilizes a complex containing Pp2a
and p70S6K, in which p70S6K is dephosphorylated and inhib-
ited.64 Activation of both the Smad pathway and Pp2a is required
for TGF-
–induced inhibition of proliferation.64 Increased expres-
sion of Igbp1 is expected to counteract the TGF-
-mediated
activation of Pp2a by sequestering Pp2aC, maintaining p70S6K
activity in the presence of TGF-
. This could explain why Igbp1
expression counteracts TGF-
–induced differentiation of SCF-
treated erythroblasts. (3) Polysome recruitment of previously
identified genes is enhanced by constitutive Igbp1 expression
(similar to eIF4E overexpression; Figure S5). This suggests that
SCF-induced expression of Igbp1 causes positive feedback in
polysome recruitment of multiple eIF4E-sensitive mRNAs, some
of which could contribute to attenuation of erythroid differentia-
tion. In line with this, another inhibitor of Pp2a, the putative
oncogene SET,65 is induced in CML,66 perhaps contributing to
differentiation arrest of the leukemic cells.
It is important to note, however, that Pp2A is a very general
phosphatase and that Igbp1 may control multiple cellular
processes in addition to phosphorylation of 4EBP and p70
S6K,30 whereas, on the other hand, Igbp1 only modulates a part
of all cellular Pp2a (70 regulatory subunits are known to
date61,62). Lack of Igbp1 results in very early embryonal
lethality,28 and knockdown of Igbp1 would not give any insight
into its importance in control of mRNA translation.
Genes regulated by selective polysome recruitment and their
tumorigenic potential
Whereas Igbp1 and mEd2 could only be expressed at restricted
levels in erythroblasts, and 4 other selected genes could not be
expressed at all, Hnrpa1 could be constitutively expressed at
abundant levels without altering the erythroblast phenotype. Hnrpa1
is involved in the generation of correct splice variants of the
erythrocyte membrane protein Band4.1,67,68 and incorrect splicing
has major consequences in vivo that may not become apparent in
vitro.69 With respect to the proteins resisting expression, there may
be a need to express them at precisely regulated levels or only
during a specific phase of the cell cycle. Notably, these genes
included Uhmk1/Kis and Cnih, which associate with and control
stability of tubulins during mitosis.70,71 Rnf138 contains ubiquitin
ligase and nuclear localization domains. Its constitutive expression
may result in degradation of essential nuclear proteins. mEd2 is
also known as MAPK-activating protein PM26,42 and its human
homolog is uncharacterised hematopoietic stem/progenitor cells
protein MDS032. Recently, mEd2 was shown to be a Q-SNARE
protein, termed D12 or Use1, involved in endoplasmic reticulum
(ER) trafficking.43,72 Interestingly, reduced expression of D12
resulted in increased phosphorylation of eIF2a. This opens the
interesting possibility that mEd2-dependent surveillance of protein
quality in the ER may also cause feedback from eIF4E activation to
polysome recruitment of mEd2 and subsequent protection of eIF2a
from inactivation by phosphorylation.
Constitutive activation of PI3K has frequently been found in
both solid tumors and leukemia.73-78 The strong inhibition of
erythroid differentiation by overexpression of eIF4E or by constitu-
tive expression of Igbp1, and the high levels of eIF4E found in
several cancer types31 indicate that regulation of mRNA translation
is a critical event in carcinogenesis downstream of PI3K. Currently,
rapamycin homologs are tested as anticancer drugs in a large
variety of tumors, yielding promising results.79-81 Although it is
generally assumed that the anticancer effect of rapamycin and its
analogs is the result of a general inhibition of protein synthesis in
proliferating cells, it is more likely that inhibition of mTOR
specifically targets structured mRNAs. Control of translation not
only regulates cell growth to reach “start” in the cell cycle but also
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is an important and selective mechanism to regulate gene expres-
sion. However, many translationally controlled genes await further
characterization with respect to regulation and function.
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